Policy & Regulation: Page 27
-
A More Efficient FDA for the Device World
A More Efficient FDA for the Device World By Denise Myshko Quicker review times are an expected result of user fees, but in the device industry they provide a valuable resource as the sector employs technological advances as part of its submissions. If user fees work for prescription drugs, they ...
By Denise Myshko • Jan. 2, 2008 -
Accurately Costing a Clinical Trial
Accurately Costing a Clinical Trial By Denise Myshko Streamlining the budget process not only leads to more accurate resource allocation, it also allows for better predictions and creates more accurate clinical-trial planning. July 2003 Clinical-trial spending has increased considerably over the ...
By PharmaVoice Team • Jan. 2, 2008 -
Explore the Trendline➔
Stock via Getty ImagesTrendlineEmerging biotech
After years of financial turmoil, the biotech market is turning the page. Strong fundamentals, including solid clinical data, are key for biotechs hoping to capitalize on the improving conditions.
By PharmaVoice staff -
Advocacy Relations: Finding Common Ground
Advocacy Relations: Finding Common Ground Forum By Elisabeth Pena Villarroel Where patient health is concerned, the goals of pharmaceutical companies and advocacy groups intersect. Teri Cox Cox Communications Partners People know about Breast Cancer Awareness Month and Prostate Cancer Awareness M...
By PharmaVoice Team • Jan. 2, 2008 -
Clinical Data Strategies for Performance Optimization
Octagon Research Solutions Inc. Data Standards Organizations that hesitate to embrace these standards as opportunities will be at a competitive disadvantage. They will continue to struggle with the tactical “cost” of transforming the ...
By PharmaVoice Team • Jan. 2, 2008 -
E-Media
New Electronic and Web-based Applications, Sites, and Technologies E-Media June 2005 PharmaVOICE SAS Upgrades Scientific Discovery Solutions In response to the need for modernization in the drug-development process, SAS Institute Inc. has made significant upgrades and additions to its Scientific ...
By PharmaVoice Team • Jan. 2, 2008 -
E-Media
November 2003E-media MDS Pharma Express is intuitive, user-friendly, and designed to operate with minimal computer requirements and the highest level of Internet security –providing easy access to current study status information in real time, anytime. MDS Electronic Data-Delivery System Allows f...
By PharmaVoice Team • Jan. 2, 2008 -
The Continuing Evolution of EDC
Paper may still reign supreme, but the EDC industry is coming of age. There is widespread agreement — at least intuitively — that the use of an electronic device or software application that allows direct data entry into electronic format has the potential to reduce time and money within the drug...
By PharmaVoice Team • Jan. 2, 2008 -
After They Walk Out the Door
After They Walk Out the Door By Elisabeth Pena Pharmaceutical companies recognize that direct-to-consumer campaigns have to address compliance with treatment regimens if they are to hold on to patients after they leave the doctor’s office. The messages in direct-to-consumer advertising are shifti...
By PharmaVoice Team • Jan. 2, 2008 -
Dr. Sidney Pestka -- A Father of Invention
Dr. Sidney Pestka — A Father of Invention by Kim Ribbink With a wealth of discoveries and other scientific achievements to his name, Sidney Pestka, Ph.D., has positioned his company — PBL Biomedical Laboratories and its subsidiary PBL Therapeutics — to lead the charge in cutting-edge research. Si...
By PharmaVoice Team • Jan. 2, 2008 -
What's New
Society of Hospital Medicine Launches New Medical Journal The Society of Hospital Medicine plans to launch a new peer-reviewed medical journal, The Journal of Hospital Medicine, in 2006. The journal will promote the science and practice of hospital medicine and the enhancement of in-patient care....
By PharmaVoice Team • Jan. 2, 2008 -
Talent Pool
Pharma POOL Kevin Guthrie Thom Rowland Solvay Promotes VPs Solvay Pharmaceuticals, Marietta, Ga., a pharmaceutical company focused on cardiology, gastroenterology, mental health, women’s health, and select specialized markets, has promoted Kevin Guthrie to VP of commercial operations, neuroscienc...
By PharmaVoice Team • Jan. 2, 2008 -
Shifting the Compliance Paradigm
VIEW on regulatory compliance Michael Kuehne is President of ACSYS Inc., Hillsborough, N.J., which specializes in developing quality and compliance solutions that combine R&D and manufacturing capabilities to deliver sustained improvement in R&D, Quality, Operations, Clinical, and Regulat...
By PharmaVoice Team • Jan. 2, 2008 -
Medicare
Medicare Campbell. Executives will continue to prepare for the new regulations approved under the Medicare Prescription Drug, Improvement and Modernization Act (MMA). These regulations will take effect as scheduled on Jan. 1, 2006. Before the full benefit’s official start, however, the industry f...
By PharmaVoice Team • Jan. 2, 2008 -
Regulatory
FDA Acts to Strengthen the Safety Program for Marketed Drugs On Nov. 5, 2004, Acting FDA Commissioner Dr. Lester M. Crawford issued the following statement: Modern drugs provide unmistakable and significant health benefits, but experience has shown that the full magnitude of some potential risks ...
By PharmaVoice Team • Jan. 2, 2008 -
Culture of Compliance: Cutting Through the Confusion
Culture of Compliance: Cutting Through the Confusion A few years after the Pharmaceutical Research and Manufacturers of America (PhRMA) code and the Office of the Inspector General (OIG) guidance, and the more recent implications of the Accreditation Council for Continuing Medical Education (ACCM...
By PharmaVoice Team • Jan. 2, 2008 -
What's on Your Mind -- Opinions
What’s on your Mind Opinions Monitoring Drug Safety The industry and the U.S. Food and Drug Administration have come under significant scrutiny since Merck’s withdrawal of Vioxx. Six papers on the issue were published on the subject in the Dec. 1, 2004, issue of the Journal of the American Medica...
By PharmaVoice Team • Jan. 2, 2008 -
Cautious Capital
The funding environment for biotech and start-up companies has improved considerably during the past few years. But venture capital investors are more cautious and more demanding than ever before. Karen Boezi Venture capital investors will increasingly be focused on capital efficiency and reducin...
By Lisa Dress • Jan. 2, 2008 -
PharmaTrax
Pharma Trax Sales, Marketing, And R&D Trends Affecting the Healthcare Industry Doctors Prefer Details by Specialty Reps In the past three years, specialty sales representatives have become an increasingly important promotional investment for pharmaceutical companies, according to Verispanís l...
By PharmaVoice Team • Jan. 2, 2008 -
Pharmacogenomics: The Next Step Forward
Pharmacogenomics The Next Step Forward The first NDA based on pharmacogenomic data may still be a long time coming, but in anticipation of such filings, the FDA has issued a draft guidance that encourages companies to conduct pharmacogenomic tests during the drug-development process. Pharmacogeno...
By Denise Myshko • Jan. 2, 2008 -
Sea Change
Sea Change Turning the tide The Product Life-Cycle Management Wave Commonly thought of as a strategy for the end-phase of a drug, life-cycle management increasingly is being deployed by life-sciences executives earlier in the development phases to maximize product value, provide greater benefits ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaOutlet
Contributed by Harry Sweeney Back to the Future Credit the Food and Drug Administration with showing up in force and spelling out its intentions clearly at Parade Magazine’s Direct-to-Consumer Advertising Draft Guidance Symposium in New York City in one of the most collegial sessions I’ve attende...
By PharmaVoice Team • Jan. 2, 2008 -
Talent Pool
Talent Pool Executive Appointments and Promotions in the Healthcare Industry Pharma POOL Dr. Vijay Aggarwal David Hurley aaiPharma Announces Two Executive Promotions aaiPharma Inc. has appointed Dr. Vijay Aggarwal, formerly president of AAI Development Services, to the role of president, research...
By PharmaVoice Team • Jan. 2, 2008 -
E-Submissions: On the Brink of Going Paperless
E-submissions On the Brink of Going Paperless By Denise Myshko The shift from static paper regulatory applications to dynamic and interactive electronic submissions will make data more accessible to reviewers and, ultimately, improve the efficiency of the review process. December 15, 2004, was a ...
By Denise Myshko • Jan. 2, 2008 -
What's New
What’s new New healthcare-related products, services, and companies PRA forms Global Medical and Safety Services Division The new business unit consolidates PRA’s risk-management activities across the company. PRA International, a clinical research organization, has formed Global Medical and Safe...
By PharmaVoice Team • Jan. 2, 2008 -
The Medical Affairs-Marketing Connection
The Medical Affairs-Marketing Connection By Denise Myshko A changing regulatory environment is mandating that there is better collaboration between the medical affairs and marketing departments of pharmaceutical companies. These two groups are forging stronger relationshiPS for better product lif...
By Denise Myshko • Jan. 2, 2008